Dr. Ward received his MD from Johns Hopkins and trained in Pediatrics, Neonatology and Clinical Pharmacology at the University of Minnesota. His research focused on perinatal, neonatal and pediatric pharmacology. Recent studies relate to opioid analgesia and the neonatal abstinence syndrome. Through the American Academy of Pediatrics (AAP), he helped develop legislation to increase pediatric studies of drugs: FDAMA, PREA and BPCA; and later served on an Institute of Medicine Committee to examine their effectiveness. At the University of Utah, he worked as a neonatologist for 30 years and consulted to the FDA, NIH, USP and AAP. In 1999, he started a pediatric clinical trials program at the University of Utah that has studied thousands of children and trains pediatric pharmacologists. As Professor of Pediatrics and Adjunct Professor of Pharmacology/Toxicology, he retired to Emeritus status in 2015. He currently serves on the Executive Committee of the Section of Clinical Pharmacology and Toxicology of the AAP, on the Board of Directors of the Institute for Advanced Clinical Trials (I-ACT) for Children and co-chairs the clinical pharmacology working group of the International Neonatal Consortium. Dr. Ward has authored over 115 peer reviewed manuscripts and 27 chapters focused mostly on pediatric pharmacology.